Alyeska Investment Group’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100,000
| Closed | -$215K | – | 524 |
|
|
2024
Q2 | $215K | Hold |
100,000
| – | – | ﹤0.01% | 480 |
|
|
2024
Q1 | $325K | Buy |
100,000
+50,000
| +100% | +$163K | ﹤0.01% | 416 |
|
|
2023
Q4 | $1.02M | Hold |
50,000
| – | – | 0.01% | 374 |
|
|
2023
Q3 | $804K | Sell |
50,000
-48,426
| -49% | -$779K | 0.01% | 412 |
|
|
2023
Q2 | $837K | Buy |
98,426
+50,000
| +103% | +$425K | 0.01% | 430 |
|
|
2023
Q1 | $478K | Hold |
48,426
| – | – | ﹤0.01% | 393 |
|
|
2022
Q4 | $462K | Sell |
48,426
-57,292
| -54% | -$546K | ﹤0.01% | 376 |
|
|
2022
Q3 | $1.84M | Sell |
105,718
-19,282
| -15% | -$335K | 0.02% | 316 |
|
|
2022
Q2 | $969K | Hold |
125,000
| – | – | 0.01% | 496 |
|
|
2022
Q1 | $1.88M | Buy |
+125,000
| New | +$1.88M | 0.02% | 438 |
|